FDA Investigating Safety of Asthma Drug Xolair
Injected medication may be linked to higher risk of heart attack, stroke, agency says,,
THURSDAY, July 16 (HealthDay News) -- The U.S. Food and Drug Administration has begun a safety review of the asthma drug Xolair
(omalizumab) after reports of an increased risk of heart attack, abnor...
Drug Xolair for Severe Asthma Xolair
(omalizumab) drug is found to be useful in treating patients with severe asthma and the new drug is approved by the European Medicines Agency (EMEA) for use in patients whose symptoms are not controlled by current drugs//. Xolair
can be used in the treatment of severe asthma patients and the...
Physicians Rank Schering-Plough's Marketing Messages for Asmanex as the Most Appealing in the Asthma Drug Market
...eport entitled Brands & Strategies Asthma also finds that
patients, on the other hand, respond most favorably to the marketing
messages for Advair and xolair
which focus on symptom improvement and
Advair's message of "Fewer Asthma Symptoms, Better Breathing," appeals
to a higher percentage...
New Asthma Medicine Targeting Vulnerable Inner-City Children Tested
...sitive to particular allergens.
The Inner City Anti-IgE Therapy for Asthma (ICATA) study involves about 50 children at each site. It will evaluate xolair
(omalizumab), a drug that binds to and inactivates IgE antibodies.
“Xolair ‘sops up’ the IgE that’s there, decreases the receptors for IgE, and re...
Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
BETHESDA, Md., April 14 /PRNewswire-FirstCall/ -- Micromet, Inc.
(Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary
antibodies for the treatment of cancer, inflammation and autoimmune
diseases, presented at the annual meeting of the American Association for
Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids
...tion in allergic
asthma attacks and further define xolair
safety profile in children age six
through 11 - th...1-year-old children, up to their 12th birthday
is the only approved therapy to block IgE, which i...million children in the US under the age
is currently approved for adults and adolescents a...